Background/Aims: Ovarian cancer is one of the most common malignancies with a high rate of mortality in women. However, current therapies for ovarian cancer treatment are ineffective. Therefore, novel target identification is an urgent requisite. The present study aimed to investigate the role of microRNA-214 (miR-214) in ovarian cancer. Methods: The expression of miR-214, β-catenin, cyclin D1, c-myc, and TCF-1 at the transcriptional level was measured by real-time PCR, while that of β-catenin, Cyclin D1, and c-Myc at the protein level were detected by western blot. Colony formation assay and transwell assay were used to explore the invasion ability of the cancer cells. Cell cycle was measured by flow cytometry. Results: Real-time PCR showed that miR-214 expression in ovarian cancer cell lines was lower than that in the human normal ovarian epithelial cells, IOSE80. Furthermore, the low expression of miR-214 was correlated with high pathological grade. The rate of colony formation and invasion of miR-214 overexpression in SKOV-3 cells were weaker than that in control cells. Moreover, miR-214 overexpression led to the G0/G1 phase arrest. The expression of β-catenin, Cyclin D1, and c-Myc was suppressed by the overexpression of miR-214. Conclusion: These results suggested that miR-214 may serve as a tumor suppressor of ovarian cancer by targeting the β-catenin pathway.
MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin
Yang
Introduction
Among the three most common gynecological malignancies, the rate of mortality of ovarian cancer is the highest, which might be attributed to the lack of early symptoms and specific and sensitive markers for the diagnosis of ovarian cancer [1, 2] . At the time of diagnosis, a majority of the women with ovarian cancer were in the advanced stages, and 70% would be deceased within 5 years [3] . Therefore, identifying the novel targets for ovarian cancer treatment is an urgent requirement.
MicroRNAs (miRNAs) are 22nt long single-stranded and non-coding RNAs, which regulate the gene expression via complementary binding to mRNA at the post-transcriptional level [4] [5] [6] [7] . miRNAs were considered as oncogenes when highly expressed in cancer cells and tissues [8] [9] [10] [11] . Conversely, the anti-oncogenic role of these miRNAs was elucidated post downregulation in cancer cells and tissues [8, 12, 13] . Therefore, the miRNA expression can indicate the prognosis of human cancers [14] [15] [16] [17] [18] . MicroRNA-214 (miR-214) has been found to be aberrantly expressed in different types of human tumors with varied roles in the development of cancers [19] [20] [21] [22] [23] [24] . For instance, the expression of miR-214 was up-regulated in melanoma and promoted cancer cell progression by targeting TFAP2C and upregulating ALCAM [25, 26] . The overexpression of miR-214 was reported in gastric [27] and cervical cancers [28, 29] . However, in most cases, miR-214 was downregulated and exerted an antioncogenic role [30] [31] [32] [33] . For example, miR-214 suppressed the cell proliferation, migration, and invasion by targeting MEK3, JNK1, Plexin-B1, and GALNT7 [29, 34, 35] in cervical cancer cells. In bladder cancer cells, miR-214 exerted tumor-suppressive effects by directly downregulating the level of PDRG1 [36] . Recently, miR-214 has been shown to induce apoptosis and sensitize breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade [37] . Nevertheless, the role of miR-214 in ovarian cancer remains controversial, while some researchers designated miR-214 as an oncogene, promoting cisplatin resistance [38] and radioresistance [39] . Interestingly, some studies suggested that miR-214 exhibits an anti-oncogenic role by suppressing the ovarian cancer cell proliferation (27) and promoting the chromosomal instability of cancer cells [40] . Therefore, the present study aimed to investigate the expression and role of miR-214 in ovarian cancer cells. Ovarian cancer tissues were histologically examined by two independent pathologists using hematoxylineosin (H&E) staining. None of the patients received any medication within 3 months before surgery. To prevent RNA degradation, the tissues were maintained in liquid nitrogen immediately after excision. The study protocol was approved and supervised by the Ethics Committee of Kunming Medical University. All patients provided written informed consent form before the experiment.
Materials and Methods

Human tissue specimens
Cell culture SKOV-3, OVCAR-3, and A2780 ovarian cancer cell lines and IOSE80 normal ovarian epithelial cell line were purchased from Yingrun Biological Co., Ltd. (Changsha, China). SKOV-3, OVCAR-3, and A2780 were cultured in 1640 medium (HyClone, USA), supplemented with 10% (v/v) fetal bovine serum (FBS; HyClone) and 1/100 penicillin-streptomycin (Invitrogen, Carlsbad, CA, USA). IOSE80 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM; HyClone) with high glucose, supplemented with 10% (v/v) FBS, supplemented with 1/100 penicillin-streptomycin. HEK-293T cell line was obtained from ATCC and cultured in DMEM containing 10% (v/v) FBS and supplemented with 1/100 penicillin-streptomycin. All cell lines were cultured in a humidified atmosphere of 5% CO 2 and 95% air at 37 °C.
Real-time PCR (RT-PCR) assay
Total RNA was extracted using TRIzol (Invitrogen), according to the manufacturer's instructions. Total RNA was subjected to cDNA synthesis and RT-PCR as described previously (2) . U6 snRNA was used as an internal standard to normalize the expression of miR-214. For the expression analysis of β-catenin, cyclin D1, c-myc, and TCF-1, β-actin was used as a reference gene. The specific primer pairs were shown in Table 1 . The expression data were analyzed using 2 -ΔΔCt method.
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
H&E staining
Tissue sections were fixed in 4% paraformaldehyde for 4 h. Then, the sections were deparaffinized in xylene and successively rehydrated with an alcohol gradient. Subsequently, the sections were H&E stained and rinsed with distilled water, followed by examination under a microscope (Olympus, Japan).
Lentivirus packaging and stable cell line establishment
MiR-214 and control mi-RNA precursors were cloned into pEZX-MR04 (GeneCopoeia TM , USA) and termed as pLV-miR-214 and pLV-miR-control, respectively. pLV-miR-214 or pLV-miRcontrol was transfected into HEK293T cells according to the manufacturer's instructions (GeneCopoeia). The transfection efficacy was evaluated by inverted fluorescence microscopy (Olympus). After 48 h, the cell supernatant was harvested, filtered, and cleared by centrifugation at 500 ×g for 10 min. Three days post-infection in SKOV3 cells, 2 μg/mL puromycin was added to screen the successfully infected cells. The sequences of miR-214 and control microRNA precursor (5'-3') were as follows: miR-214, forward: ACAGCAGGCACAGACAGGCAGU, reverse:
UGCCUGUCUGUGCCUGCUGUUU; control, forward: ACAGCAGGCACAGACAGGCAGU, reverse: UGCCUGUCUGUGCCUGCUGUUU. The cells transfected with pLV-miR-214 were termed as SKOV-3-miR-214, and pLV-miRcontrol-transfected cell line was named as SKOV-3-miR-Control. The expression of miR-214 was detected by real-time PCR.
Western blot analysis Cells were lysed using RIPA lysis buffer (Beyotime, China). The BCA protein assay kit (Pierce, Rockford, IL, USA) was used to evaluate the protein concentration. An equivalent amount of protein (30 mg) was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12% SDS-PAGE) and transferred to polyvinylidene fluoride (PVDF) membrane. Then, the membranes were incubated with 5% non-fat milk for 60 min and probed with primary antibodies to b-catenin (Cell Signaling Technology, Danvers, MA, USA; 1:1000), Cyclin D1 (Cell Signaling Technology, 1:1000), c-Myc (Cell Signaling Technology, 1:1000), TCF-1 (Cell Signaling Technology, 1:1000), and b-actin (Abcam, Cambridge, UK 1:1000) overnight at 4 °C. Then, the membranes were incubated with the corresponding HRP-conjugated secondary antibodies for 2 h at room temperature. Consequently, the bands were visualized using an enhanced chemiluminescence system (ECL, Pierce).
Cell colony assay SKOV-3-miR-214 and SKOV-3-miR-Control cells were cultured for 2 weeks in soft agar plates, respectively. Subsequently, the colonies were observed using an inverted phase contrast microscope. The colony formation ratio was calculated using the following equation: colony formation ratio (%) = (number of colonies/number of seeded cells) × 100.
Cell cycle
Cells were lysed and fixed in ice-cold 75% ethanol for 24 h at 4 °C. Then, propidium iodide (PI) was added, and the cells placed in the dark for 30 min. The cell cycles were analyzed using flow cytometry (Beckman Coulter, USA).
Transwell assay SKOV-3-miR-214 cells (SKOV-3-miR-control and WT SKOV-3) were pre-incubated for 24 h at 37 °C, followed by detachment and resuspended in serum-free medium. A total of 6000 cells were seeded in the upper chamber, and 10% serum medium was placed as a chemoattractant in the lower chamber of Matrigel- 
coated transwells. After incubation for 9 h, the membranes were fixed with methanol for 1 h and stained with 1% crystal violet. Finally, the membranes were placed on a glass slide and scanned using a microscope (Olympus, Japan). The number of migrating cells in five fields per chamber was counted and averaged.
Statistical analysis
Student's t-test or one-way ANOVA was used for statistical analysis when appropriate. All statistical analyses were performed using SPSS 19.0 (SPSS Inc., Chicago, IL, USA). A two-tailed P-value < 0.05 was considered to be statistically significant.
Results
MiR-214 expression was downregulated in ovarian cancer cells and tissues
RT-PCR was used to investigate the expression of miR-214 in ovarian cancer cells and tissues. The tissues were examined by H&E staining (Fig. 1A) . No significant differences were observed in the expression level of miR-214 between benign ovarian tumor tissues and normal ovarian tissues. However, the malignant tissues had a significantly lower expression level of miR-214 than the innocent ovarian tumor and normal tissues (P < 0.05, Fig. 1B ). The expression was inversely correlated with the pathological grade (Fig. 1B) . Furthermore, the miR-214 expression in ovarian cancer cell lines was significantly lower than in the ISOE 80 cells (P < 0.05, Fig. 1C ). These results suggested the potential tumor suppressor role of miR-214 in ovarian cancer.
miR-214 overexpression inhibited the colony formation and cell invasion
To explore the physiological role of miR-214 in ovarian cancer cells, it was stably transfected into SKOV-3 cells; and the construct was termed as SKOV-3-miR-214. The transfection efficiency was measured by a microscope and the miR-214 expression confirmed by RT-PCR (Fig. 2) . Then, the colony formation ability was detected. As expected, the colony formation ability of SKOV-3-miR-214 was dramatically decreased as compared to the SKOV-3-control and WT SKOV-3 cell lines (Fig. 3A-B) . Apparently, the growth and proliferation of SKOV-3-miR-214 were inhibited by the overexpression of miR-214 (Fig. 3C) . The transwell invasion assay was conducted to investigate cancer progression since the invasion is a critical feature in cancer. As shown in Fig. 4 , the invasion capacity of SKOV-3-miR-214 cells was significantly lower than the SKOV-3-miR-control and WT SKOV-3 cells. These results indicated that the overexpression of miR-214 abrogated ovarian cancer invasion capacity and colony formation ability. 
miR-214 overexpression led to cell cycle arrest
Next, we speculated that the overexpression of miR-214 might be involved in cell cycle. Compared to SKOV-3-Control and WT SKOV-3 cell lines, a higher ratio of SKOV-3-miR-214 cells was observed in the G1/S phase (Fig. 5) . These results indicated that miR-214 might inhibit cell proliferation by inducing cell cycle arrest in the G1/S phase. miR-214 suppressed β-catenin pathway β-catenin was reported to be involved in the downstream physiological mechanism of miR-214 in different types of cancer cells [41] [42] [43] [44] [45] . Therefore, the expression of β-catenin, as well as its downstream proteins, including CyclinD1, c-Myc, and TCF-1, was assessed by western blot and RT-PCR. As shown in Fig. 6 , the mRNA expression of β-catenin, cyclin D1, and c-myc in SKOV-3-miR-214 cells was significantly higher than that in SKOV-3-control and WT SKOV-3 cells. On the other hand, the mRNA expression of TCF-1 was similar among the three groups. Furthermore, western blot analysis revealed that the expression of β-catenin, Cyclin D1, c-Myc, and TCF-1 in SKOV-3-miR-214 cells was significantly lower than that in SKOV-3-control and WT SKOV-3 cells (Fig. 6 ). Taken together, these results suggested that miR-214 may suppress the expression of β-catenin in SKOV-3 cells.
Discussion
The role of miR-214 remains controversial in ovarian cancer cells. The present study revealed that miR-214 expression was downregulated in ovarian cancer tissues and cells. Furthermore, the miR-214 expression was negatively correlated to the pathological grade. Functional studies revealed that miR-214 overexpression lowered the invasion ability and transwell migration ability of the cancer cells and impeded the cell cycle. In addition, β-catenin was found to be involved in the physiological role of miR-214. These results indicated that miR-214 might be a tumor suppressor in ovarian cancer.
An in-depth understanding of the physiological and pathophysiological mechanisms of miRNAs may provide a novel strategy for the diagnosis and therapy of diseases [6, 46, 47] . The present study demonstrated that miR-214 was downregulated in ovarian cancer cells and negatively related to the pathological grade, thereby designating its role as a tumor suppressor in ovarian cancer. These results were in agreement with those from previous studies [28, 30, 37, 43, [48] [49] [50] [51] . Furthermore, to explore the tumor suppressor role of miR-214, we constructed the stably expressing miR-214 SKOV-3 cell lines and examined its effect on the cellular function. Results showed that the overexpression of miR-214 inhibited the colony formation, which was consistent with that described previously [29, 36, 38] . Also, the overexpression of miR-214 led to ovarian cancer cell cycle arrest at G1/S phase, similar to the previous results [50] .
MiRNAs exerted a physiological effect on the cellular function by regulating the gene expression; Plexin-B1, PTEN, p53/Nanog, and Wnt/β-catenin pathways have been identified as targets of miR-214 [45, 52] . Among these, Wnt/β-catenin pathway was involved in the embryonic development, self-renewal of the tissue [53] , and cell proliferation [54, 55] . In the present study, the expression of β-catenin, Cyclin D1, TCF-1, and c-Myc was downregulated in SKOV-3-miR-214 cells, which was confirmed by miR-214-mediated inhibition on Wnt/β signaling pathway [42, 43] . Conclusion miR-214 may act as a tumor suppressor in ovarian cancer, indicating that it might serve as a target for the treatment of ovarian cancer. However, additional studies are essential to reveal the precise mechanisms underlying miR-214 in ovarian cancer.
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